Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120. - Wikidata - wikimedia - TriplyDB

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

http://www.wikidata.org/entity/Q44382993

about

Catalytic antibodies to HIV: physiological role and potential clinical utility Beyond new chemical entities: advancing drug development based on functional versatility of antibodies Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.Beneficial catalytic immunity to abeta peptide.Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.Physiological IgM class catalytic antibodies selective for transthyretin amyloid.Back to the future: covalent epitope-based HIV vaccine development.IVIg treatment reduces catalytic antibody titers of renal transplanted patients Specific amyloid β clearance by a catalytic antibody construct.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.Constant domain-regulated antibody catalysis.CD4 binding determinant mimicry for HIV vaccine design.Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccine Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Catalytic antibodies and their applications in biotechnology: state of the art.A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis.Antibody-Mediated Catalysis in Infection and Immunity.A covalent HIV vaccine: is there hope for the future?Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection.Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog.Autoantibody-catalyzed hydrolysis of amyloid beta peptide.

P2860

Q24655912-F920E7FD-FC3A-4FCF-8276-5DBF41F0A04B Q30386064-D0EA4F0F-8BB1-43D7-B4D1-85B259595242 Q30481770-1C0446F4-CCA0-4699-9FCB-BCA0109ED7A8 Q33549900-5E9CAB63-700D-47C9-9443-A3769E22C371 Q33573668-F856488A-EE5D-4818-9709-99F74E0248C3 Q33676625-4D9987AD-1F45-4F83-B60F-A9FAC7EE742E Q34597300-66EDDD52-7497-4D81-90EA-AB7CC8C68C13 Q34962680-E5A97EEF-BA9A-4308-8F61-1EDC98318514 Q35451085-28295834-4083-461F-B766-C79078313EE3 Q35880109-E3CE802D-D6F8-4798-AA2F-873F9842C0F9 Q36069818-7BE8391B-F3AF-40FE-B05A-355BE40031AB Q36332826-FD255EB1-912D-4DEB-B2C4-6B97D5C832C3 Q36469664-D3BA4B86-44A8-40B3-808D-DDDED2F71A12 Q37000547-733C2CDB-E2EF-464E-AD52-1464A9D2AF49 Q37127735-36826FE8-2108-4D1B-958E-070D68EF094A Q37431843-32C060EF-3B62-4042-A738-C8379568A403 Q37944291-CBD4491D-15AB-48DC-BC88-BE2C29385414 Q38197955-A1F41932-0496-48E0-9410-1126B0CD663A Q38290090-3C411857-CE31-4A8D-8CD2-4C3D47B720A8 Q38743675-F83C4409-DE7B-4F78-AD2A-90FC157F1FD8 Q39412526-A2DF35E3-A957-4530-B2F2-BFE68780315D Q39733091-1D936CA0-5D4F-4416-8881-163FB43C3BA0 Q40909337-8C70ED4F-9C35-46E2-9BA1-96012BF229BC Q44693889-0A7E19F2-0CDE-4FB3-896A-3A8F30667676 Q44745703-7C802D8A-1A49-4495-8C2F-A51E53193AD8 Q46845401-5AEBCED6-FE88-46ED-BA0C-84E2950D2768

P2860

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

http://www.wikidata.org/entity/Q44382993

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

@en

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

@nl

type

label

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

@en

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

@nl

prefLabel

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

@en

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

@nl

P1433

Q44382993-ADC98F89-E6FC-4079-911F-3D467EBFDDA4

P1476

Q44382993-0989B2AE-54BA-4416-9C8B-7AE39A25E6F0

P2093

Q44382993-B3138709-DB70-41A4-A531-FBB6B7A9BFD5

Q44382993-BF7EA99F-D0BC-4380-B1C5-5333B18DFE49

Q44382993-C0F3D2B1-13DC-422B-8D0E-6F5B11A771F1

Q44382993-CB14A101-9750-41B2-8BE0-D7AEA27AFB42

Q44382993-D1C2B366-C0E7-4408-A45F-9CA35AA25250

Q44382993-D52F43A9-DF09-4A5C-B393-077821182121

Q44382993-E26A07A0-939D-4B30-BA04-0A1957212BD2

Q44382993-E8182036-E02B-49B6-9F00-3C18C10FC839

P2860

Q44382993-02895792-9D3F-4219-9849-5081F61FCEFC

Q44382993-071658D1-8D73-49FD-BC27-10A6CA820401

Q44382993-11926496-E49F-411C-A4F3-CDB8B00BFE87

Q44382993-261D266A-B755-419F-9BA8-2421A72FB51A

Q44382993-3891F0EA-BDE3-4533-9790-DE793CB7329C

Q44382993-4284D2F0-D160-4908-83F3-A24752B95D0F

Q44382993-52249304-2503-4DF1-A7C6-463993224140

Q44382993-5A0188B7-486D-4639-ACD0-BCDFC7F1BB3B

Q44382993-5A1AE830-E5FD-4402-B04A-AA6A2E5BA0E8

Q44382993-7305D5C3-4C52-4311-9D09-21353ABB75B9

P304

Q44382993-C77FE25B-E4B2-4CAC-93E9-3AF7B346D5C4

P31

Q44382993-AE08DB09-584C-4E52-A8DD-DB58953F429E

P356

Q44382993-96FE4F5E-5EAD-412B-B477-B4F6CF8337A9

P407

Q44382993-CABE28D0-5DAF-43A3-B009-9174CBD0FD75

P433

Q44382993-6D3F77EF-B6C9-45B4-97AA-422723119242

P478

Q44382993-F5A90491-90E5-494D-AA9D-0CD94F405AB2

P577

Q44382993-D224E09A-C0E9-4544-A747-EFB67BCC6AC3

P698

Q44382993-61049CCE-DDAB-4A98-8FDC-99863E284F56

P921

Q44382993-D79A9CDD-B8F5-420B-9AC3-6FE0D92CDDD2

P356

P1433

Journal of Biological Chemistry

P1476

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

@en

P2093

Carl Hanson

http://www.w3.org/2001/XMLSchema#string

Gita Bhatia

http://www.w3.org/2001/XMLSchema#string

Hiroaki Taguchi

http://www.w3.org/2001/XMLSchema#string

Sangeeta Karle

http://www.w3.org/2001/XMLSchema#string

Stephanie Planque

http://www.w3.org/2001/XMLSchema#string

Sudhir Paul

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Nishiyama

http://www.w3.org/2001/XMLSchema#string

Yong-Xin Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a catalytic antibody with a serine protease active site

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.

A suicide-substrate mechanism for hydrolysis of beta-lactams by an anti-idiotypic catalytic antibody.

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus.

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes.

Flexibility and molecular recognition in the immune system.

Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?

From molecular diversity to catalysis: lessons from the immune system.

Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen.

P304

20429-20435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M300870200

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12665517

http://www.w3.org/2001/XMLSchema#string

P921